Plexus Corp. (NASDAQ:PLXS – Get Free Report) CEO Todd Kelsey sold 1,500 shares of the firm’s stock in a transaction dated Wednesday, August 19th. The stock was sold at an average price of $250.98, for a total value of $376,470.00. Following the sale, the chief executive officer directly owned 65,888 shares in the company, valued at $16,536,570.24. This trade represents a 2.23% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Plexus Stock Down 1.0%
PLXS traded down $2.35 on Thursday, reaching $241.91. The company’s stock had a trading volume of 231,792 shares, compared to its average volume of 332,131. The stock has a 50 day moving average of $271.06 and a two-hundred day moving average of $242.31. The company has a quick ratio of 0.72, a current ratio of 1.49 and a debt-to-equity ratio of 0.06. The company has a market capitalization of $6.47 billion, a price-to-earnings ratio of 35.68 and a beta of 0.90. Plexus Corp. has a fifty-two week low of $126.86 and a fifty-two week high of $307.06.
Plexus (NASDAQ:PLXS – Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The technology company reported $2.32 earnings per share for the quarter, topping analysts’ consensus estimates of $2.13 by $0.19. Plexus had a net margin of 4.03% and a return on equity of 12.46%. The company had revenue of $1.30 billion for the quarter, compared to analysts’ expectations of $1.23 billion. During the same quarter last year, the company earned $1.64 earnings per share. The firm’s revenue for the quarter was up 28.2% on a year-over-year basis. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. As a group, analysts forecast that Plexus Corp. will post 7.11 EPS for the current fiscal year.
Hedge Funds Weigh In On Plexus
Wall Street Analyst Weigh In
Several equities analysts have issued reports on PLXS shares. Sidoti raised Plexus from a “neutral” rating to a “buy” rating and set a $308.00 price objective on the stock in a report on Friday, July 31st. Wall Street Zen raised Plexus from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Zacks Research raised Plexus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. Weiss Ratings cut Plexus from a “buy (b)” rating to a “buy (b-)” rating in a research report on Tuesday, August 11th. Finally, Stifel Nicolaus raised their price target on Plexus from $280.00 to $330.00 and gave the stock a “buy” rating in a research note on Monday, June 22nd. One research analyst has rated the stock with a Strong Buy rating and six have assigned a Buy rating to the company. According to data from MarketBeat.com, Plexus currently has an average rating of “Buy” and an average target price of $273.00.
Check Out Our Latest Research Report on PLXS
About Plexus
Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
Further Reading
- Five stocks we like better than Plexus
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
